Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Synovus Financial Corp. (SNV): Are Hedge Funds Right About This Stock?

Page 1 of 2

Is Synovus Financial Corp. (NYSE:SNV) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Is Synovus Financial Corp. (NYSE:SNV) the right investment to pursue these days? Hedge funds are in a pessimistic mood. The number of bullish hedge fund positions decreased by 5 lately. SNV was in 21 hedge funds’ portfolios at the end of September. There were 26 hedge funds in our database with SNV positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Opko Health Inc. (NYSE:OPK), ABIOMED, Inc. (NASDAQ:ABMD), and Bright Horizons Family Solutions Inc (NYSE:BFAM) to gather more data points.

Follow Synovus Financial Corp (NYSE:SNV)
Trade (NYSE:SNV) Now!

If you’d ask most traders, hedge funds are viewed as worthless, old investment vehicles of yesteryear. While there are over an 8000 funds in operation at present, Our researchers choose to focus on the masters of this club, about 700 funds. These investment experts oversee the lion’s share of the hedge fund industry’s total asset base, and by shadowing their first-class picks, Insider Monkey has unsheathed a number of investment strategies that have historically outrun Mr. Market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Now, we’re going to take a peek at the latest action regarding Synovus Financial Corp. (NYSE:SNV).

What does the smart money think about Synovus Financial Corp. (NYSE:SNV)?

At the end of the third quarter, a total of 21 of the hedge funds tracked by Insider Monkey were long this stock, a change of -19% from one quarter earlier. With hedge funds’ sentiment swirling, there exists a select group of notable hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Millennium Management, managed by Israel Englander, holds the biggest position in Synovus Financial Corp. (NYSE:SNV). Millennium Management has a $93.9 million position in the stock, comprising 0.2% of its 13F portfolio. On Millennium Management’s heels is Matthew Lindenbaum’s Basswood Capital, with a $65.4 million position; the fund has 3.2% of its 13F portfolio invested in the stock. Some other professional money managers that are bullish consist of Ken Griffin’s Citadel Investment Group, Mark Lee’s Forest Hill Capital and Richard S. Pzena’s Pzena Investment Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!